First in human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 with antitumour activity in advanced BRCA-deficient and sporadic cancers
ANNALS OF ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2011)